BJU International

Article	Citations
Reply to ‘Comment on Bertini et al.: area deprivation and PSA screening disparities’ and ‘Comment on socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivati	92
Response to Chen et al.	71
The European Association of Urology talent incubator: bridging competencies for holistic urological care	60
Acupuncture: a promising adjuvant strategy for pain management among the patients with prostate cancer	59
	53
April's reviewers of the month	53
Efficacy of RestoreX after prostatectomy: open‐label phase of a randomised controlled trial	50
Recent key papers in prostate cancer	47
The LANDMARK project: providing summaries of key papers that have shaped urological practice	46
Editorial Board	44
	41
Flexible ureterorenoscopy or extracorporeal shockwave lithotripsy in stone disease and bevacizumab for hereditary and sporadic papillary renal‐cell cancer	38
September's reviewers of the month	36
Author Index	36
MRI , Prostate cancer diagnosis, and Artificial Intelligence; What are the implications?	35
Age‐related PSA testing for prostate cancer: NICE recommendation 1.6.3	33
Editorial Board	33
Synchronous vs independent reading of prostate‐specific membrane antigen positron emission tomography ( PSMA‐PET) and magnetic resonance imaging (	32
Vitamin C as an adjunct to methenamine hippurate use after ALTAR: ego or evidence‐based?	31
Comment on: ‘Residents surgical training using metrics for transurethral resection of bladder tumours’	31
Issue Information	31
Beyond pass or fail: Enhancing the rigour in urological artificial intelligence examination assessment	30
ChatGPT – Integrity: Artificial Intelligence Misuse in Medical Writing	28
Sexual function in adolescence after childhood hypospadias repair: a patient‐reported outcome study	28
Building a research profile during residency	27

Patient‐side performance metrics and errors in robotic surgery: Junior‐ European Association of Urology Robotic Urology Section/Young Academic Urologists (J‐ ERUS	27
Response to comment by Semwal et al.	27
	27
June's reviewers of the month	27
Benchtop comparison of seven ureteroscopes: evaluating physical properties and deflection with flexible and navigable suction access sheaths	26
Defining a new national undergraduate urology curriculum in the UK using consensus‐based methodology	26
Eve's and Adam's rib for prostate cancer screening	26
Prolonged ischaemia during partial nephrectomy: impact of warm vs cold	25
Response to comments on ‘Adverse in‐hospital outcomes in patients with paraplegia who undergo radical prostatectomy’	25
Ablative radiotherapy in castration‐resistant prostate cancer	25
Surveillance of non‐muscle ‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis	25
Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?	25
Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension	24
Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial	24
Active surveillance versus enzalutamide for low‐risk prostate cancer – was it really a trial we needed?	23
MRI in combination with Technetium‐99m‐sestamibi single‐photon emission CT/CT: a novel diagnostic algorithm to maximise the characterisation of small renal masses	23
The impact of post‐nephroureterectomy surgically induced chronic kidney disease on survival outcomes	23
Feasibility and outcomes of interventions to reduce cystoscopy discomfort: a multi‐site pilot study	23
Frail and forgotten: an EAU YAU call for trainee‐led research on frailty in urology	23
Prediction Analysis of Microarray of 50 genes ( PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami	22
‘Igloo’ technique for robot‐assisted radical prostatectomy – maximum nerve sparing for early recovery of continence and sexual function	22
Ureterorenoscopy during normothermic machine perfusion: effect of varying renal pelvis pressure	22
Reply to ‘Comment on novel MRI ‐ US fusion with advanced annotation in focal cryoablation for pros	22
Validation of a prediction model for post‐chemotherapy fibrosis in nonseminoma patients	21
A meta‐analysis of Retzius‐sparing and hood‐technique robot‐assisted radical prostatectomy	21
Non‐significant does not mean uninformative – but poor reporting can be misleading	21
Opportunistic prostate‐specific antigen testing in Norwegian men: a public health challenge	20
Analgesic efficacy of rectus sheath catheter is non‐inferior to thoracic epidural catheter	20
The diagnostic value of MRI for persistent prostate cancer following irreversible electroporation focal therapy	20
Can exercise increase natural killer cell infiltration of the prostate?	20
How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway	19
	19
Table of Contents	19
Editorial Board	19
August's reviewers of the month	19
September's reviewers of the month	19
	19
Why prompting matters: achieving clinically accurate and consistent responses with Chat GPT	19
Correction to “Outcomes of BCG vs upfront radical cystectomy for high‐risk non‐muscle‐invasive bladder cancer”	18
Is Gleason 6 cancer? The answer is more than just a ‘name’	18
Micro‐ and nanoplastics in the human genitourinary system: oncological impact – a systematic review	18
Issue Information	18
Response to: ‘Balancing sheath–scope size in flexible ureteroscopy’	18
Sustainability in urology – are we doing enough?	18
Quality‐of‐life outcomes of the ROBOtic‐assisted versus Conventional Open Partial nephrectomy (ROBOCOP) II trial	18
Reply to ‘A mitochondrion‐centric approach to guide treatment de‐escalation in advanced prostate cancer’ by Su et al.	18
Correction to ‘Complications of vasectomy: results from a prospective audit of 105 393 procedures’	18
Lateral drainage metal ureteric stent for the treatment of ‘Y‐shaped’ branch obstructive uropathy	18
Caval thrombectomy a urological leap into the unknown – a call for action	18
Area deprivation and cancer‐specific mortality in non‐muscle‐invasive bladder cancer: a statewide analysis	17

Thulium fibre laser lithotripsy, the new standard?	17
Precision by recognition: smarter firing for better lithotripsy	17
Artificial intelligence‐based approaches to augmenting and automating surgical training	17
Sepsis prevalence and associated hospital admission and mortality after ureteroscopy in employed adults	17
Venous thromboembolism after penile cancer surgery: a UK PeCaN study	17
The effect of different assays on prostate‐specific antigen testing	17
Guideline of guidelines: Peyronie's disease	16
The prostate cancer electronic health ( eHealth) literacy instrument: a tool for eHealth design an	16
Progress in the management of stone disease	16
The rapid assessment for prostate imaging and diagnosis ( RAPID ) prostate cancer diagnostic pathway	16
VI‐RADS followed by Photodynamic Transurethral Resection of Non‐Muscle‐Invasive Bladder Cancer vs White‐Light Conventional and Second‐resection: the ‘CUT‐ less	16
Can only AI save us from the burden of administration?	16
Preferences between three options for androgen deprivation therapy: a focus group study	16
Comparison of serum and plasma microRNA expression levels in patients with germ cell tumours	16
A novel flexible vacuum‐assisted ureteric access sheath in retrograde intrarenal surgery	16
Issue Information	15
Editorial Board	15
	15
Incidence, risk factors, and temporal trends of penile cancer: a global population‐based study	15
	15
Urologist underutilisation of androgen receptor pathway inhibitors for metastatic hormone‐sensitive prostate cancer	15
Scribe smarter, not harder: how artificial intelligence scribes stack up against human clinicians	15
Cystectomy and lymphadenectomy – we now node how far to go!	15
	15
Revisiting patient selection and treatment planning in the VIOLETTE trial of targeted microwave ablation	15
Issue Information	15
Definitive local therapy for T4 prostate cancer associated with improved local control and survival	14
Prevalence of germline pathogenic variants in 779 patients with metastatic prostate cancer	14
‘ Case of the Month’ from the First Hospital of Sanming, Fujian Medical University, China: management of a renal haematoma with pyelonephritis and ne	14
	14
Key ingredients for running a randomised controlled trial in a surgical day unit	14
Response to Zhu et al.	14
Inhibition of phosphodiesterases 1 and 4 prevents myofibroblast transformation in Peyronie's disease	14
Response to ‘Endpoint and control group in prostate cancer screening research: public health basics’	14
Vascular closure devices in living‐donor nephrectomy: a much‐needed systematic review and meta‐analysis focusing on safety	14
Long‐term outcomes of cribriform‐positive and cribriform‐negative prostate cancer treated with radical prostatectomy in the ProtecT trial	13
Improving detection of carcinoma in situ in bladder cancer: urinary cytology vs the Xpert® BC Monitor	13
Non‐infectious adverse events of transperineal prostate biopsies performed under local anaesthesia	13
Developing an artificial intelligence model for phase recognition in robot‐assisted radical prostatectomy	13
Bladder irrigation with tap water to reduce antibiotic use for urinary tract infections in catheter users	13
Re‐defining the interpretation of 24‐h urine studies for stone formers	13
Development of an optically transparent kidney model for laser lithotripsy research	13
Potential safety concerns in use of the artificial intelligence chatbot ‘ChatGPT’ for perioperative patient communication	13
Comment on ‘Artificial intelligence‐based approaches to augmenting and automating surgical training’	13
In vivo ureteroscopic intrarenal pressures and clinical outcomes: a multi‐institutional analysis of 120 consecutive patients	13
Hydraulic and malleable female‐to‐male penile implants after phalloplasty in transgender individuals: a retrospective cohort analysis	13
An MRI/PET PSMA‐based phase I–II study of salvage high‐dose‐rate brachytherapy after surgery and radiotherapy	13
‘ BJUI Clinical Dilemma’: Recurrent high‐grade non‐muscle‐invasive bladder cancer in 2026	13
Functional outcomes of robot‐assisted partial nephrectomy in patients with a solitary kidney	13
Clinical presentation of bacille Calmette–Guérin ( BCG ) infections after	12
Ureteric stenting after uncomplicated ureteroscopy: a systematic review of surgeons’ motivations and patient experiences	12
There is more to disposable endoscopes than whether they work…	12
Google infodemiology and temporal trends in benign prostatic hyperplasia surgery in Australia	12
Deep learning‐based classification of acute scrotum using single ultrasound images	12
Single‐port robot‐assisted nephroureterectomy via a supine anterior approach: step‐by‐step technique	12
Evaluating the predictors of poor corporal integrity in penile implant recipients	12
The challenges of conducting a surgical trial—reflections on the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial	12
Table of Contents	12
Mesorectal nodal metastasis with seminal vesicle invasion in biochemically recurrent prostate cancer	12
Editorial Board	12
Comment on ‘Clinical features of medication‐related osteonecrosis of the jaw in prostate cancer management’	12
Use of a microdebrider for epithelial excision during vaginectomy/colpocleisis in patients undergoing metoidioplasty	12
Outcomes after laser enucleation of the prostate with and without significant storage symptoms	12
Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population‐based study	11
Stone volume instead of maximum stone diameter: results from an international survey	11
Complete response in metastatic renal cell carcinoma: impact of a persistent primary lesion	11
Prognostic value of programmed death ligand‐1 and programmed death‐1 expression in patients with upper tract urothelial carcinoma	11
Methodological concerns on prostate‐specific membrane antigen ( PSMA) immunohistochemistry for predicting PSMA	11
Recovery and immune function after low pressure pneumoperitoneum during robot‐assisted radical prostatectomy: a randomised controlled trial	11
Issue Information	11
November's reviewers of the month	11
Prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: does it really have an effect on oncological outcomes?	11
Comment on ‘Can ChatGPT pass the urology fellowship examination? Artificial intelligence capability in surgical training assessment’	11
Female non‐obstetric urogenital fistula repair: long‐term patient‐reported outcomes and a scoping literature review	11
Cisplatin‐ineligible patients with muscle‐invasive bladder cancer demonstrate poor long‐term survival following immediate radical cystectomy	11
Catheterisation after urethral lengthening in transgender/gender‐diverse individuals: a randomised controlled trial (Safe Access for Bladder Entry in Transgender Men Following Penile Reconstruction [	11
A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy	11
Recommendation on the use of protective eyewear in endourological laser procedures	10
Response to ‘Comment on robot‐assisted partial nephrectomy using the Hugo™ RAS system: first multicentre study’	10
Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta‐analysis	10

Impact of prostate mpMRI quality on diagnostic accuracy in prostate cancer: a prospective study	10
Alternate‐day administration of intravesical gemcitabine and docetaxel to improve clinic utilisation	10
Response to: ‘Indirect evidence and cautious sequencing in indeterminate testicular lesions’	10
Oncological outcomes after attempted nerve‐sparing radical prostatectomy (NSRP) in patients with high‐risk prostate cancer are comparable to standard non‐NSRP: a longitudinal long‐term propensity‐matc	10
Contemporary outcomes in non‐muscle‐invasive bladder cancer: a large European multicentre study	10
Focal therapy using a novel cooled laser device for prostate cancer: early trial results	10
Greenlight laser prostatectomy: which goggles are best for visualising haematuria accurately?	10
Positive surgical margin and oncological outcomes after robot‐assisted radical prostatectomy in different Cancer of the Prostate Risk Assessment risk groups	10
Initial surveillance in men with marker negative clinical stage IIA non‐seminomatous germ cell tumours	10
The value of maintenance therapy in intermediate‐risk non‐muscle‐invasive bladder cancer	10
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging	10
Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti‐tumour T‐cell activation – IRE ‐	10
F‐SHARP: a Phase I/II trial of focal salvage high‐dose‐rate brachytherapy for Radiorecurrent prostate cancer	10
Impact of intraprostatic PSMA maximum standardised uptake value following prostatectomy: a systematic review and meta‐analysis	9
Real‐world outcomes for high‐risk non‐muscle‐invasive bladder cancer: screened patients for the BRAVO trial	9
Prostate morcellation devices: a systematic review and meta‐analysis of clinical outcomes and efficiency	9
Editorial Board	9
Perspectives on technology: Single‐use catheters – evidence and environmental impact	9
The first step in shared decision‐making for prostate cancer screening	9
Robot‐assisted single‐port transvesical enucleation of the prostate: step‐by‐step technique and early single‐centre experience	9
Re: ‘The perioperative outcomes of papillary versus non‐papillary access in percutaneous nephrolithotomy’	9
May's reviewers of the month	9
A call for regimen agnostic circulating tumour DNA ‐guided adjuvant selection in muscle‐invasive bladder cancer	9
Fluid management and suction in endourology	9
A comment on: ‘Prevalence of urolithiasis in China: a systematic review and meta‐analysis’	9
Surgical cystectomy training using human cadavers embalmed using Thiel's method: a pilot study	9
Big trials in prostate cancer | predicting drug response in bladder cancer | immune checkpoint inhibitors for urothelial carcinoma | hydrochlorothiazide in the prevention of kidney stone recurrence	9
A systematic review on artificial intelligence evaluating PSMA PET scan for intraprostatic cancer	9
Learning curve for fusion magnetic resonance imaging targeted prostate biopsy and three‐dimensional transrectal ultrasonography segmentation	9
Response to Daungsupawong and Wiwanitkit: RE: The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2	9
Issue Information	9
Total pelvic exenteration surgery for loco‐regionally advanced prostate cancer, is it justifiable?	9
Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade	9
Iatrogenic ureteric injuries after abdominal surgery: a systematic review and meta‐regression from the European Association of Urology Endourology Section	9
A mitochondrion‐centric approach to guide treatment de‐escalation in advanced prostate cancer	9
Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal function	9
	9
Deep‐learning segmentation to guide bladder neck recognition in robot‐assisted radical prostatectomy	9
June's reviewers of the month	9
Immunotherapy‐based neoadjuvant treatment and complication rates after radical cystectomy	9
Systematic review of PSA reference intervals in the gender diverse population with prostates	8
Various dimensions of sexual self‐concept in middle‐aged men after vasectomy: a matched analysis	8
Combined therapy with dutasteride and tadalafil vs dutasteride or tadalafil monotherapy in benign prostatic hyperplasia: a randomised phase III trial	8
	8
Alternative instillation techniques of sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer	8
Stapled vs totally handsewn robotic intracorporeal neobladder: perioperative and functional outcomes	8
Use of bulbospongiosus muscle for repair of traumatic posterior urethral stenosis combined with urethrorectal fistulas	8
Comment on ‘Stone dust in endourology: a systematic review of its definition, management, and clinical impact’	8
Socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivation Index on PSA screening frequency	8
A novel two‐stage approach to the treatment of renal cell carcinoma with intra‐cardiac tumour extension and Budd–Chiari syndrome	8
Increasing trend of utilising active surveillance for Gleason Score 7 (3 + 4) prostate cancer	8
Patient‐reported outcomes: active surveillance vs radical therapies in low‐risk prostate cancer	8
Economic analysis of minimally invasive surgical treatments for BPH in the Australian public healthcare system	8
Impact of perioperative nutrition on recovery after radical cystectomy: a randomised trial	8
Is analgesic efficacy of rectus sheath catheter actually non‐inferior to thoracic epidural catheter?	8
Clinical features of medication‐related osteonecrosis of the jaw in prostate cancer management	8
Impact of ischaemia duration and clamping strategy in patients with solitary kidney undergoing partial nephrectomy	8
Retzius‐sparing robot‐assisted radical prostatectomy in renal transplant recipients	8
Added value of randomised biopsy to multiparametric magnetic resonance imaging‐targeted biopsy of the prostate in a contemporary cohort	8
A TREXIT Catalyst: an updated review of NHS England prostate biopsy data during	8
Trends in treatment and survival of older vs younger patients with renal cancer between 2011 and 2022	8
August's reviewers of the month	8
What are we missing? Identifying clinically significant prostate cancer among patients with low PSA : the utility of the free‐to‐total	8
Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer	8
Low‐ versus standard‐ pneumoperitoneum in patients undergoing robot‐assisted radical prostatectomy: a randomised, triple‐blinded study	8
A randomized controlled trial investigating rectus sheath catheters following radical cystectomy	8
Cystoscopic application of RADA16 peptide for refractory haematuria from radiation cystitis	8
Outcomes of maintenance BCG versus gemcitabine/docetaxel following BCG induction in NMIBC	7
Comment on: ‘Preferences between three options for androgen deprivation therapy…’	7
Case of the Month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses	7
Long‐term multicentre analysis of robot‐assisted radical cystectomy for non‐muscle‐invasive bladder cancer	7
Perspectives on technology: All STEPS count – an integrated framework for net zero urological care	7
Recovery of iatrogenic erectile dysfunction with somatic‐to‐autonomic sural nerve graft	7
Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics	7
Depictions of penises in historical paintings reflect changing perceptions of the ideal penis size	7
The growing valuable role of urology clinical nurse specialists in the United Kingdom	7
Adverse in‐hospital outcomes in patients with paraplegia who undergo radical prostatectomy	7
Response to the letter by Kleebayoon et al. Re: Sui et al. ‘Re‐defining the interpretation of 24‐h urine studies for stone formers’	7
Prognostic impact of histological discordance between transurethral resection and radical cystectomy	7
Accuracy of MRI in detecting seminal vesicle invasion in prostate cancer: a systematic review and meta‐analysis	7
Issue Information	7
Table of Contents	7
	7
Reply to ‘Letter Re: Ejaculatory function following transperineal laser ablation vs TURP for benign prostatic obstruction’	7
Accuracy of cognitive vs software‐guided MRI ‐targeted biopsy in predicting final grading at prostatectomy	7
Impact of audit and feedback on transurethral resection of bladder tumour quality: a monocentric post‐completion evaluation of the RESECT trial	7
Comment on ‘Peri‐operative outcomes of open, laparoscopic and robotic simple prostatectomy’	7
Intravenously engrafted human multilineage‐differentiating stress‐enduring (Muse) cells rescue erectile function after rat cavernous nerve injury	7
The superficial circumflex iliac artery ( SCIA ) flap in Phalloplasty: Don't “ SCIP ” patient sele	7
Issue Information	7
Response to Brönimann et al. 'The Challenges of Conducting a Surgical Trial – Reflections on the EBRUC II Trial'	7
Is there any difference between cognitive and fusion transrectal biopsies if performed by residents?	7
	7
Incidence and risk factors for postoperative vaginal events following radical cystectomy for bladder cancer: a nationwide population‐based study	7
Comment on ‘Renal, bladder and prostate cancer surgery outcomes with respect to team familiarity’	7